←
Cholangiocarcinoma Foundation11,233 posts
Cholangiocarcinoma Foundation avatar✓

Cholangiocarcinoma Foundation ✓

@curecc

Our mission is to find a cure and improve the quality of life for individuals affected by cholangiocarcinoma. #CCAhope

◷ Joined July 2009▧ 2,652 Photos and videos
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·16h

This holiday season, we are reminded of how much hope, support, and community can mean to someone facing cholangiocarcinoma. 💚 Just one day after her 60th birthday, Ingrid received a devastating diagnosis: stage IV perihilar cholangiocarcinoma. Like so many others, she had never heard of bile duct cancer before it became part of her life. Reflecting on her experience, Ingrid shares, “CCF gave me support, education, connection, and hope. Those of us facing this disease need hope the most.” Through Candles for the Cure, your generosity helps make that hope possible by supporting critical research and providing resources and connection for patients and families. 🕯️ Light a candle for someone you love. Your gift will be doubled dollar for dollar, thanks to a generous $16,000 matching gift from Bob and Gladys Schussel in loving memory of their daughter, Jilly Coyle. Give today at curecca.link/c4c27,

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 16

🔬 We are pleased to announce a new data partnership with Tempus AI, leveraging their Lens platform to power real-world research. CCF has funded a half-time post-doctoral fellow for two years to analyze Tempus’ multimodal BTC dataset alongside the CCF Research Team and external research collaborators. This dataset combines Tempus biomarker test results along with EHR-derived variables, including other biomarker test results, demographics, clinical characteristics, treatments, and outcomes. With a cohort size of approximately 4,500 individuals, this dataset complements CCF’s existing data resources [Komodo Healthcare Map (insurance claims) and International Cholangiocarcinoma Patient Registry (medical records)].  We will be introducing the Tempus team and their dataset to the ICRN on Dec. 4, 2026, at 10:00 a.m. Eastern / 4:00 p.m. CET.  Do you have a research question that could be addressed by the Tempus dataset or one of our other data resources? ICRN members are invited to submit project proposals for review by the ICRN Data Committee. Approved investigators are granted access to these data sources, along with analytic support (subject to project needs and scoping). Learn more and submit your project proposals at cholangiocarcinoma.org/data-… or contact research@curecca.org. 🔗 Register for the December 4 session: curecca.link/tempusAI.

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 15

🕯️ Finding Support After Loss The holidays can be especially difficult when you’ve lost someone you love. CCF’s bereaved programs are here to help you connect, share, and find comfort. 💚 During this season, you are not alone; support and understanding are here for you whenever you need them. Together, we can share memories, find comfort, and honor those we’ve lost. 👉 Request a bereaved caregiver mentor: curecca.link/BereavedMentor 💚 Join a bereaved support group: curecca.link/bereaved

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 13

📣 Registration is open for Liver Cancer Therapies: Advancing the Frontiers of Transplant Oncology. Join the University of Maryland School of Medicine on December 11 for a continuing medical education event focused on the latest advances in liver cancer research, treatment, and transplant oncology. This is a Continuing Medical Education (CME) Event. Join clinicians and researchers on December 11 for a day of learning and discussion exploring the latest developments in liver cancer treatment, research, and transplant oncology. 📅 December 11, 2026 🕘 9 a.m.–4:30 p.m. 📍 MSTF Leadership Hall 🎓 Free CME event | Registration required The program will highlight the scope of the liver cancer program at the University of Maryland Medical Center, current research directions, and emerging treatment approaches. 🔗 Register: umaryland.cloud-cme.com/cour…

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 13

At CCF, we know that navigating any aspect of a cholangiocarcinoma journey can be overwhelming, including accessing and understanding biomarker testing. We're here to help. Our Patient Advocacy Team can support you in advocating to get biomarker testing, better understanding the results, and exploring targeted treatment options and clinical trials.  Head to curecca.link/patientadvocate or the link in our bio to get connected today. 💚

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 12

Thank you Patty Maxin for attending the Inaugural Understanding Policies, Innovations and Decisions: Patient and Caregiver Regulatory Symposium. A patient-focused symposium designed to help patients, caregivers and support teams better understand the policies, processes and practical decisions that shape the transplant journey. Opportunities like these help empower our community with knowledge, encourage meaningful conversations and ensure patient and caregiver perspectives remain part of the conversation.

Post attachment
Wungki Park, MD MS avatar
⟳ Cholangiocarcinoma Foundation retweeted
Wungki Park, MD MS@CentralParkWMD·Nov 12

A little overdue but too meaningful not to share! 💚 #RASevangelist in BTC💚 Fantastic 8th Annual #Cholangiocarcinoma Summit! Honored to discuss the evolving landscape of #KRAS / #RAS inhibition and what comes next for #CCA #cholangiocarcinoma @HardingJJMD many opportunities ahead! @nasca_vincenzo @honestytheis @JavleMilind Shiraj Sen, Jordi Roldon, Sunyoung Lee, Richard Kim, Olumide Gbolahan From molecularly targeted therapies to rational combinations, the opportunities are expanding! 🧬 Wonderful science, colleagues and friends united by one mission: better outcomes for patients with biliary tract cancer. #BiliaryTractCancer #PrecisionOncology #GRIT @curecc @MSKCancerCenter @MSK_DeptOfMed

Post attachmentPost attachmentPost attachmentPost attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 12

🧬 Today is Cancer Biomarker Awareness Day! 🧬 Cancer biomarker testing is transforming cancer care, helping ensure patients receive the most effective treatments based on their tumor’s unique molecular profile. However, far too many patients still miss the opportunity to be tested in a timely manner. Biomarker testing should happen before treatment decisions are made. Clinicians, advocates, patients, and communities all play a role in raising awareness, educating, and advocating for equitable access to testing. Join us in spreading the word and empowering patients to ask for timely testing.  Ask your doctor if biomarker testing could impact your treatment options. #CBAD26 Learn more at biomarkersmatter.org.

Post attachment
Stacie Lindsey avatar
⟳ Cholangiocarcinoma Foundation retweeted
Stacie Lindsey@staclinds·Nov 9

We invite patients w/cholangiocarcinoma and their caregivers, along with healthcare providers, to upcoming @curecc Regional Symposia: Houston on Dec. 11, Bethesda on Feb. 11, and Seattle on Feb. 26. Learn more and register here: cholangiocarcinoma.org/regio…

Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 10

Registration for the 14th Annual Cholangiocarcinoma Foundation Conference is now open. 🎉 Join researchers, clinicians, patients, caregivers, and advocates for a weekend of connection, presentations on the latest advancements in cholangiocarcinoma research, and a community united by hope. The event is in-person only, and everyone is invited to attend the scientific sessions. There will be 1-2 patient- and caregiver-focused breakout sessions on March 23-24.  Register today at: curecca.link/ac2027.

Post attachment
Cholangiocarcinoma Foundation avatar
Cholangiocarcinoma Foundation@curecc·Nov 8

Thank you to Susan Camberis for organizing Smoke Out Cholangiocarcinoma in memory of her beloved husband, James “Jim” Camberis. Jim was a devoted husband, father, family member, and friend who loved good food and BBQ. In honor of what would have been his 58th birthday, Susan brought family, friends, and community members together this October to celebrate Jim’s life and support the cholangiocarcinoma community. Thanks to Susan’s heartfelt efforts and the generosity of everyone who participated, $14,475 was raised for the Cholangiocarcinoma Foundation! Susan, thank you for turning your love for Jim into meaningful support for others affected by this disease. Every dollar helps advance research, strengthen patient and caregiver support, and raise awareness of cholangiocarcinoma. We are honored to be part of Jim’s legacy and grateful to everyone who helped make this event possible. 💚

Post attachmentPost attachmentPost attachment